The Research and Development team at Asher Biotherapeutics focuses on innovating and advancing targeted immunotherapy solutions for cancer and other diseases. This multidisciplinary team conducts cutting-edge research, oversees in vivo operations, and develops drug substances, while also translating scientific discoveries into viable therapeutic candidates. Their collaborative efforts aim to streamline the path from bench to bedside, ensuring effective treatment options for patients.
View all